Cargando…

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database

The potent oral inhibitor of BCL2, venetoclax (VEN), used to treat adults with chronic lymphocytic leukaemia, has been approved in US for the treatment of naïve patients with acute myeloid leukemia (AML) unfit for intensive chemotherapy and recently in Europe, too. However, the drug has been used fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gozzo, Lucia, Vetro, Calogero, Brancati, Serena, Longo, Laura, Vitale, Daniela Cristina, Romano, Giovanni Luca, Mauro, Elisa, Fiumara, Paolo Fabio, Maugeri, Cinzia, Parisi, Marina Silvia, Dulcamare, Ilaria, Garibaldi, Bruno, Duminuco, Andrea, Palumbo, Giuseppe Alberto, Di Raimondo, Francesco, Drago, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660092/ https://www.ncbi.nlm.nih.gov/pubmed/34899303 http://dx.doi.org/10.3389/fphar.2021.748766

Ejemplares similares

Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
por: Brancati, Serena, et al.
Publicado: (2021)

Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data
por: Gozzo, Lucia, et al.
Publicado: (2023)

Therapeutic innovation for multi-resistant candidemics: Synergy of isavuconazole and caspofungin association
por: Duminuco, Andrea, et al.
Publicado: (2021)

Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field
por: Duminuco, Andrea, et al.
Publicado: (2022)

Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases
por: Duminuco, Andrea, et al.
Publicado: (2022)

Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting
por: Duminuco, Andrea, et al.
Publicado: (2022)

Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience
por: Duminuco, Andrea, et al.
Publicado: (2023)

The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries
por: Gozzo, Lucia, et al.
Publicado: (2023)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries
por: Gozzo, Lucia, et al.
Publicado: (2021)

Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue
por: Brancati, Serena, et al.
Publicado: (2021)

Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries
por: Gozzo, Lucia, et al.
Publicado: (2022)

A case of high‐risk AML in a patient with advanced systemic mastocytosis
por: Fazio, Manlio, et al.
Publicado: (2023)

Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
por: Palumbo, Giuseppe A., et al.
Publicado: (2023)

P1558: PROPHYLAXIS WITH TIXAGEVIMAB-CILGAVIMAB IN SINGLE-CENTER EXPERIENCE CAN REDUCE SEVERE COMPLICATIONS RELATED TO SARS-COV-2 INFECTION IN HEMATOLOGICAL PATIENTS
por: Duminuco, Andrea, et al.
Publicado: (2023)

Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network
por: Gozzo, Lucia, et al.
Publicado: (2017)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
por: Gozzo, Lucia, et al.
Publicado: (2020)

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap
por: Gozzo, Lucia, et al.
Publicado: (2020)

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
por: Gozzo, Lucia, et al.
Publicado: (2020)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
por: Yang, Yang, et al.
Publicado: (2022)

Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution
por: Gozzo, Lucia, et al.
Publicado: (2022)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Immunological Dysregulation in Multiple Myeloma Microenvironment
por: Romano, Alessandra, et al.
Publicado: (2014)

P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
por: Duminuco, Andrea, et al.
Publicado: (2023)

Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study
por: Markovic, Uros, et al.
Publicado: (2021)

Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia
por: Romano, Alessandra, et al.
Publicado: (2017)

Editorial: Innovative treatments for neuro-psychiatric diseases
por: Gozzo, Lucia, et al.
Publicado: (2023)

AIPSS‐MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib
por: Duminuco, Andrea, et al.
Publicado: (2023)

Fluoxetine Protects Retinal Ischemic Damage in Mice
por: Romano, Giovanni Luca, et al.
Publicado: (2023)

Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports
por: Pennisi, Maria Stella, et al.
Publicado: (2023)

Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology
por: Milone, Giuseppe, et al.
Publicado: (2022)

Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future
por: Duminuco, Andrea, et al.
Publicado: (2023)

PB1993: EXPRESSION OF NEO-201 MAY HELP IN THE DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
por: Duminuco, Andrea, et al.
Publicado: (2023)

Salvage Therapy of Multiple Myeloma: The New Generation Drugs
por: Romano, Alessandra, et al.
Publicado: (2014)

MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes
por: Giallongo, C., et al.
Publicado: (2023)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
por: Drago, Filippo, et al.
Publicado: (2020)

Dictionary of pharmacovigilance /
por: Alghabban, Amer
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_8fr7dh7ndjfqmeq1cl3922ld0i